VCEL Vericel Corp

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business: advanced autologous cell therapies and specialty biologics for sports medicine and severe burn care markets
• • New product launch: MACI Arthro arthroscopic delivery system approved August 2024 and commercially available Q3 2024 with custom instruments

Risk Factors

• • Regulatory risk: potential penalties from FDA or state agencies for off-label promotion or anti-kickback/anti-bribery law violations
• • Geopolitical risk: supply disruption of NexoBrid due to Middle East conflicts or China-Taiwan tensions, impacting commercial success

Management Discussion & Analysis

• • Revenue not explicitly stated, but sales volume increase indicated by accounts receivable growth and higher net income $16.5M in 2025 vs $10.4M in 2024
• • Net income $16.5M (2025), operating expenses include $38.8M stock compensation, no explicit margin % reported

Risk Factors

• • New FDA operational risk from 2025 federal employee layoffs affecting review of MACI Ankle IND and clinical trial enrollment start in H2 2025
• • Most material update: disruptions and leadership resignations at FDA causing potential delays in inspections and approvals of manufacturing facilities

What are the latest VCEL SEC filings in 2026?

Vericel Corp (VCEL) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 6, 2025, an 8-K current report on May 1, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did VCEL file its most recent 10-K annual report?

Vericel Corp (VCEL) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view VCEL 10-Q quarterly reports?

Vericel Corp (VCEL)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every VCEL 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has VCEL filed recently?

Vericel Corp (VCEL)'s most recent 8-K was filed on May 1, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find VCEL insider trading activity (Form 4)?

SignalX aggregates every VCEL Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does VCEL file with the SEC?

Vericel Corp (VCEL) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new VCEL filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Vericel Corp (VCEL).

What is VCEL's SEC CIK number?

Vericel Corp (VCEL)'s SEC CIK (Central Index Key) number is 887359. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 887359 to look up all VCEL filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find VCEL return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Vericel Corp (VCEL) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.